For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
Blog
Two Million Jobs Will Disappear Due to Obamacare, CBO Predicts; Deficit to Rise
“The new healthcare law will slow economic growth over the next decade, costing the nation about 2.3 million jobs and contributing to a $1 trillion…
Legal Brief
Halbig v Sebelius – Joint Appellate Appendix
A group of small business owners (and individuals) in six states filed a lawsuit on May 2, 2013 against the federal government over an IRS…
Legal Brief
Halbig v Sebelius – Appellants’ Opening Brief on Appeal
A group of small business owners (and individuals) in six states filed a lawsuit on May 2, 2013 against the federal government over an IRS…
Blog
CEI Experts on the State of the Union
ECONOMIC MOBILITY Iain Murray, Vice President for Strategy: “The fact is: Today’s America is divided between those who work…
Blog
CEI Podcast for January 23, 2014: CEI Appeals Affordable Care Act Lawsuit Verdict
General Counsel Sam Kazman explains the case's importance not just for health care, but for the rule of law.
Wall Street Journal
General Mills Has A Soggy Idea For Cheerios
This month General Mills announced that it would begin labeling its flagship product, the breakfast cereal Cheerios, as containing no ingredients from GMOs (genetically modified…